OMIC Stock Overview
A life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Singular Genomics Systems, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$21.68 |
52 Week High | US$23.41 |
52 Week Low | US$5.34 |
Beta | 1.51 |
11 Month Change | 53.32% |
3 Month Change | 241.96% |
1 Year Change | 76.26% |
33 Year Change | -94.73% |
5 Year Change | n/a |
Change since IPO | -97.19% |
Recent News & Updates
Shareholder Returns
OMIC | US Life Sciences | US Market | |
---|---|---|---|
7D | -4.7% | -7.2% | -1.2% |
1Y | 76.3% | 1.2% | 30.4% |
Return vs Industry: OMIC exceeded the US Life Sciences industry which returned 1.2% over the past year.
Return vs Market: OMIC exceeded the US Market which returned 30.4% over the past year.
Price Volatility
OMIC volatility | |
---|---|
OMIC Average Weekly Movement | 39.5% |
Life Sciences Industry Average Movement | 8.8% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.5% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: OMIC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: OMIC's weekly volatility has increased from 23% to 39% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 255 | Drew Spaventa | www.singulargenomics.com |
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
Singular Genomics Systems, Inc. Fundamentals Summary
OMIC fundamental statistics | |
---|---|
Market cap | US$54.11m |
Earnings (TTM) | -US$86.32m |
Revenue (TTM) | US$2.67m |
20.3x
P/S Ratio-0.6x
P/E RatioIs OMIC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OMIC income statement (TTM) | |
---|---|
Revenue | US$2.67m |
Cost of Revenue | US$4.02m |
Gross Profit | -US$1.35m |
Other Expenses | US$84.97m |
Earnings | -US$86.32m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -34.59 |
Gross Margin | -50.77% |
Net Profit Margin | -3,236.67% |
Debt/Equity Ratio | 8.4% |
How did OMIC perform over the long term?
See historical performance and comparison